Back to AZN Stock Lookup

AstraZeneca (AZN) –

May 22, 2015 04:22 PM Amgen to terminate participation in co-development and commercialization of brodalumab
May 20, 2015 09:00 AM Olympic Gold Medalist Jackie Joyner-Kersee Teams up with AstraZeneca to Raise Awareness about Opioid-Induced Constipation
May 16, 2015 09:30 AM MOVANTIKTM (naloxegol) Safety Analyses of Opioid-Induced Constipation Patients 65 and Older with Chronic Non-Cancer Pain
May 13, 2015 05:00 PM AstraZeneca to Update on Progress with Immuno-Oncology Pipeline and Combination Treatments at ASCO 2015
May 13, 2015 12:44 PM Form 6-K ASTRAZENECA PLC For: May 13
May 13, 2015 06:18 AM AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
May 11, 2015 01:02 PM Pennsylvania Bio Announces Chairman-Elect and New Board Members
May 8, 2015 01:19 PM Form 6-K ASTRAZENECA PLC For: May 08
May 8, 2015 10:01 AM Form 6-K ASTRAZENECA PLC For: May 08
May 7, 2015 12:46 PM Form 6-K ASTRAZENECA PLC For: May 07
May 7, 2015 09:32 AM AstraZeneca (AZN) loses appeal over Pulmicort Respules patent - Bloomberg
May 1, 2015 12:30 PM Form 6-K ASTRAZENECA PLC For: May 01
May 1, 2015 12:24 PM Form 6-K ASTRAZENECA PLC For: May 01
Apr 29, 2015 03:53 PM Form 6-K ASTRAZENECA PLC For: Apr 24
Apr 29, 2015 07:10 AM AstraZeneca (AZN) Granted Priority Review for BRILINTA
Apr 29, 2015 07:00 AM US FDA Grants Priority Review for Potential New Indication for BRILINTA
Apr 27, 2015 10:00 AM GlaxoSmithKline (GSK) Gains on Speculation Pfizer (PFE) is Eyeing the Company
Apr 24, 2015 01:44 PM Form 6-K ASTRAZENECA PLC For: Apr 24
Apr 24, 2015 11:59 AM Form 6-K ASTRAZENECA PLC For: Apr 24
Apr 24, 2015 09:35 AM Form 6-K ASTRAZENECA PLC For: Apr 24
Apr 24, 2015 09:16 AM AstraZeneca (AZN) Enters Collaboration to Accelerate Development of Innate Pharma's IPH2201
Apr 24, 2015 09:02 AM Form 6-K ASTRAZENECA PLC For: Apr 24
Apr 23, 2015 08:08 AM AstraZeneca's (AZN) R&D Arm, Juno Therapeutics (JUNO) Report Immuno-Oncology Clinical Trial Collaboration
Apr 23, 2015 08:00 AM MedImmune and Juno Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
Apr 23, 2015 08:00 AM MedImmune and Juno Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
Apr 23, 2015 06:19 AM Form 6-K ASTRAZENECA PLC For: Apr 23
Apr 21, 2015 07:09 AM AstraZeneca (AZN) to Join Bina Alliance Program (RHHBY)
Apr 21, 2015 07:00 AM Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina’s Genomic Management Solution
Apr 17, 2015 10:30 AM "Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC
Apr 17, 2015 07:29 AM Form 6-K ASTRAZENECA PLC For: Apr 17
Apr 15, 2015 12:46 PM Societe Generale Starts AstraZeneca (AZN) at Buy
Apr 15, 2015 08:46 AM Form 6-K ASTRAZENECA PLC For: Apr 15
Apr 15, 2015 08:37 AM Form 6-K ASTRAZENECA PLC For: Apr 15
Apr 14, 2015 02:16 PM AstraZeneca (AZN) Moves to Session Highs; Onglyza Receives Positive FDA Panel Vote on Heart Risk
Apr 13, 2015 08:00 AM PatientsLikeMe and AstraZeneca Announce Global Research Collaboration
Apr 13, 2015 07:31 AM AstraZeneca (AZN) Will Conduct Confirmatory Macrilen Phase 3
Apr 10, 2015 08:28 AM AstraZeneca (AZN) Decline Tied to ONGLYZA FDA Briefing Docs
Apr 9, 2015 08:12 AM MedImmune's (AZN) MEDI8897 Receives FDA Fast-Track Designation
Apr 9, 2015 08:00 AM MEDI8897 Receives Fast Track Designation by the FDA for the Prevention of Respiratory Disease Caused by RSV in Infants
Apr 7, 2015 04:11 PM AstraZeneca (AZN) Selects Regulus Therapeutics (RGLS) RG-125 for NASH Treatment in Patients with Type 2 Diabetes
Apr 2, 2015 09:40 AM Nektar Therapeutics (NKTR) Receives $100M MOVANTIK-Related Milestone Payment (AZN)
Apr 1, 2015 10:02 AM Form 6-K ASTRAZENECA PLC For: Apr 01
Apr 1, 2015 09:04 AM Pharmacyclics (PCYC) Initiates Ibrutinib Combo Phase Ib/II in NSCLC (AZN)
Apr 1, 2015 07:15 AM Myriad Genetics (MYGN), AstraZeneca (AZN) Expand Lynparza Development Collaboration
Mar 31, 2015 09:11 AM Nektar Therapeutics (NKTR) Announces U.S. Launch of MOVANTIK (AZN)
Mar 31, 2015 09:00 AM MOVANTIK™ (naloxegol) Tablets for the Treatment of Opioid-Induced Constipation in Adult Patients with Chronic Non-Cancer Pain Launched in the US
Mar 30, 2015 12:37 PM Form 6-K ASTRAZENECA PLC For: Mar 30
Mar 30, 2015 09:00 AM BRILINTA Receives US FDA Approval for New Administration Option
Mar 30, 2015 08:30 AM Maryland Regional Biotech Forum Aims to Propel Washington, D.C. Metro Region to a Top Three Ranked U.S. Biotech Hub by 2023
Mar 19, 2015 10:31 AM Form 6-K ASTRAZENECA PLC For: Mar 19

Back to AZN Stock Lookup